What Is PGT/PGD and How Has the Terminology Evolved?
Preimplantation Genetic Testing is an umbrella term covering three distinct tests performed on embryos created through IVF before they are transferred to the uterus. The older label 'PGD' has largely been replaced by PGT to reflect the technology's expanded scope.
PGT-A (Aneuploidy) screens all 24 chromosomes for copy-number errors — the most common cause of IVF failure and miscarriage. PGT-M (Monogenic) diagnoses specific inherited single-gene disorders such as thalassaemia, sickle-cell disease, spinal muscular atrophy, or BRCA-related cancers. PGT-SR (Structural Rearrangements) evaluates embryos from parents carrying chromosomal translocations or inversions that repeatedly produce unbalanced offspring.
In Mumbai's clinical landscape, PGT-A is the most frequently requested test, especially among women over 35 pursuing IVF in clinics across Bandra and Andheri. PGT-M, while less common, is critically important for Maharashtra's communities where thalassaemia carrier rates are notably higher than the national average. HomeIVF's care coordinators help patients distinguish which test — or combination — applies to their specific clinical picture before a single rupee is spent on a biopsy.
Who Should Consider Genetic Testing Before Embryo Transfer in Mumbai?
Not every IVF patient needs PGT, but specific clinical profiles make genetic testing a strongly recommended conversation. Mumbai's reproductive specialists — coordinated through HomeIVF — typically recommend evaluation for the following groups.
Women aged 37 and above have a significantly higher proportion of aneuploid eggs; by 40, more than 60% of embryos may carry chromosomal abnormalities, making PGT-A a cost-effective strategy to avoid futile transfers. Couples who have experienced two or more recurrent pregnancy losses should consider PGT-SR or PGT-A to identify whether chromosomal factors are responsible. Patients with two or more failed IVF cycles despite good-quality embryos on morphology grading benefit from PGT-A to detect 'silent' aneuploidy that standard grading cannot detect.
Carriers of autosomal recessive conditions — particularly relevant in Mumbai's Gujarati, Sindhi, and certain South Indian communities where conditions like Gaucher disease or thalassaemia cluster — should pursue PGT-M with genetic counselling before cycle start. Male factor infertility with very low sperm counts or abnormal sperm DNA fragmentation also correlates with higher embryo aneuploidy rates, making PGT-A a rational addition. HomeIVF offers a structured eligibility checklist to help couples in Thane and Navi Mumbai decide confidently.
Talk to a Fertility Expert — Free
Book a free consultation. Our specialists will guide you on the right path, including Home IVF.
or chat on WhatsApp →The PGT Process: Step-by-Step From Stimulation to Transfer
Understanding the PGT workflow removes anxiety from what can feel like a complex, multi-stage protocol. The process begins identically to a standard IVF cycle: ovarian stimulation, egg retrieval, fertilisation, and embryo culture to the blastocyst stage (Day 5 or 6).
At the blastocyst stage, an embryologist performs a trophectoderm biopsy — removing 5-8 cells from the outer layer that will become the placenta, leaving the inner cell mass that forms the baby entirely intact. This minimally invasive step has no proven adverse effect on embryo viability when performed by a skilled embryologist. The biopsied cells are sent to a certified genetic laboratory — Mumbai has several NABL-accredited facilities capable of Next Generation Sequencing (NGS), the current gold standard for PGT-A analysis.
During the 10-14 days awaiting results, embryos are vitrified (snap-frozen) at the clinic. A genetic counsellor, coordinated by HomeIVF, then reviews results with the couple, explaining which embryos are euploid (chromosomally normal) and eligible for transfer. A frozen embryo transfer (FET) cycle is then planned. For PGT-M, an additional 6-12 weeks of pre-cycle probe development by the genetics lab is required before biopsy can even begin — a timeline HomeIVF helps patients plan around to avoid delays.
PGT Diagnostics: Labs, Technology, and Quality Standards in Mumbai
The reliability of PGT results depends almost entirely on laboratory quality. In Mumbai, patients have access to labs using Next Generation Sequencing (NGS), which can simultaneously analyse all 24 chromosomes with far greater resolution than older FISH (Fluorescence In Situ Hybridisation) technology. FISH is now considered outdated for PGT-A and should be avoided.
For PGT-M, the laboratory must develop a customised probe specific to the couple's genetic mutation — a process requiring DNA samples from both partners and ideally an affected family member. This is why the 6-12 week pre-cycle window is non-negotiable. Array Comparative Genomic Hybridisation (aCGH) is an alternative to NGS for structural rearrangement cases and remains in use in some Mumbai centres.
HomeIVF coordinates with NABL-accredited genetic laboratories and ensures that couples in areas like Andheri West or Thane are not inadvertently sent to facilities lacking quality certification. The HomeIVF Medical Board reviews every lab partnership annually against ICMR guidelines and international ESHRE standards to ensure patients receive clinically sound, defensible results. Patients receive a plain-language genetic report summary alongside the raw lab data.
Cost and Timelines for PGT/PGD in Mumbai
Genetic testing adds cost and time to an IVF cycle, and Mumbai patients rightly want transparent information before committing. The genetic biopsy procedure itself, the lab sequencing, and genetic counselling are typically billed separately from the core IVF protocol — and costs vary depending on whether PGT-A, PGT-M, or PGT-SR is required, and how many embryos are biopsied.
HomeIVF offers IVF packages starting from ₹1.5 lakh, with PGT add-ons quoted transparently based on the number of blastocysts and the specific test type — ensuring Mumbai patients can budget without hidden surprises. PGT-M is generally more expensive than PGT-A due to the bespoke probe development process, and this is a legitimate clinical cost, not an arbitrary markup.
Timeline-wise, a PGT-A cycle adds approximately 6-8 weeks to a standard IVF cycle (stimulation + biopsy + results + FET). PGT-M adds 3-5 months from initial genetic counselling to embryo transfer. HomeIVF care coordinators map out a personalised timeline for each Mumbai patient at the outset so that work, family, and emotional planning can happen in parallel with medical treatment rather than being disrupted by unexpected delays.
How HomeIVF Delivers Genetic Counselling and Fertility Care Across Mumbai
Mumbai's geography is both an asset and a challenge — world-class clinics exist in Bandra, Andheri, and South Mumbai, but traffic, work schedules, and the city's relentless pace mean that patients in Thane or Navi Mumbai can spend more time commuting to appointments than the appointments themselves take. HomeIVF was designed to solve this structural problem without compromising clinical rigour.
Through HomeIVF's platform, patients access senior-specialist genetic counsellors via video consultation from anywhere in Mumbai — an important first step that historically required taking half a day off work. Hormone monitoring blood draws during stimulation are conducted at home by trained phlebotomists, with results reviewed by the HomeIVF Medical Board. Follicle monitoring scans are coordinated at partner clinics in patients' local areas rather than requiring travel to a central hub.
For PGT-M cases requiring probe development, HomeIVF coordinates sample collection, lab liaison, and result communication on behalf of the couple, reducing the administrative burden that often causes delays. The HomeIVF model does not replace the clinic or embryologist — it wraps senior-specialist oversight around every step so that patients feel guided, informed, and supported throughout what is inherently a complex, emotionally charged process.
Overcoming Local Barriers: Why Mumbai Patients Delay or Avoid PGT
Despite Mumbai's clinical sophistication, several barriers cause patients to delay or forgo PGT even when it is clinically indicated. The first is information asymmetry — patients frequently receive a recommendation for 'genetic testing' without understanding which test, why, or what the results will mean for their cycle. This ambiguity breeds hesitation.
The second barrier is cost anxiety. Without transparent package pricing, patients assume PGT will make an already expensive IVF cycle prohibitive and self-select out of a potentially cycle-saving intervention. The third barrier is time — particularly acute in Mumbai, where a 6-12 week pre-cycle requirement for PGT-M feels daunting to couples already stressed by years of infertility treatment.
HomeIVF addresses each barrier directly. The platform provides structured genetic counselling before any commitment, translating clinical recommendations into personalised decisions. Transparent pricing with no hidden consultation fees removes cost anxiety. And HomeIVF's project-management approach to PGT-M timelines — beginning probe development in parallel with lifestyle optimisation and cycle preparation — compresses the perceived waiting time into productive months rather than frustrating delays. Patients in Navi Mumbai and Thane particularly benefit from this model, where the distance from major fertility hubs previously made genetic counselling feel inaccessible.
Success Archetypes: Who Typically Benefits Most From PGT in Mumbai?
While HomeIVF does not publish individual patient stories without consent, clinical data supports several recurring profiles where PGT delivers the most meaningful improvement in outcomes.
The first archetype is the 'morphologically good embryo, repeated failure' couple — both partners are younger than 38, embryo grading looks excellent on Day 3, yet two or three transfers have ended in chemical pregnancy or early miscarriage. PGT-A frequently reveals that morphologically 'good' embryos were aneuploid, explaining failure and redirecting treatment toward euploid embryos with meaningfully higher live birth rates.
The second archetype is the carrier couple — often identified through premarital or prenatal screening, particularly common in Mumbai's Gujarati and Sindhi communities, where consanguinity and community endogamy increase carrier concordance. PGT-M allows these couples to have biological children without passing on a devastating genetic condition, often described by patients as 'the most important decision we ever made.'
The third archetype is the 40+ Mumbai professional who has frozen embryos from a previous egg-freezing cycle and now wants PGT-A before FET to maximise the chance of success with limited remaining embryos. HomeIVF's counselling helps these patients understand their euploid embryo rate realistically and plan accordingly.
Frequently Asked Questions
Is PGT-A the same as PGD? What is the difference?+
PGD (Preimplantation Genetic Diagnosis) was the older term used for both chromosomal screening and single-gene disorder testing. International guidelines now use PGT as the umbrella term: PGT-A screens for chromosomal number errors (aneuploidy), PGT-M diagnoses single-gene disorders, and PGT-SR evaluates structural chromosomal rearrangements. Most Mumbai fertility clinics now use PGT terminology, but older literature and some practitioners may still use PGD interchangeably. HomeIVF's genetic counsellors clarify which specific test applies to each patient.
Does embryo biopsy for PGT damage the embryo?+
When performed by a trained embryologist at the blastocyst stage, trophectoderm biopsy has not been shown to reduce embryo viability in high-quality clinical studies. The 5-8 cells removed come from the layer destined to become the placenta, leaving the inner cell mass — which forms the baby — entirely untouched. Mumbai's accredited IVF laboratories follow strict ESHRE biopsy protocols. It is, however, a technically demanding procedure and outcomes depend significantly on the embryologist's skill and the laboratory's quality controls.
How many embryos do I need to make PGT-A worthwhile in Mumbai?+
Most genetic counsellors recommend having at least 2-3 blastocysts available for biopsy to make a PGT-A cycle clinically and financially meaningful. If only one blastocyst is available, the probability that it is euploid varies from roughly 70% in women under 35 to under 40% in women over 40. With a single embryo, some couples choose to proceed to transfer without PGT-A, while others prefer the certainty of testing. HomeIVF's counselling helps Mumbai patients weigh this trade-off based on their specific age, history, and embryo cohort.
What genetic conditions can PGT-M detect before embryo transfer?+
PGT-M can be designed to detect virtually any single-gene disorder for which the causative mutation has been identified. Commonly tested conditions in Mumbai include beta-thalassaemia, sickle-cell disease, spinal muscular atrophy (SMA), cystic fibrosis, Duchenne muscular dystrophy, Huntington's disease, and BRCA1/2 mutations linked to hereditary breast and ovarian cancer. The laboratory requires 6-12 weeks to develop a bespoke probe for each mutation before the IVF cycle begins. Both partners and ideally an affected family member must provide DNA samples for probe validation.
How long does the full PGT process take from first consultation to embryo transfer in Mumbai?+
For PGT-A, the total timeline from first consultation to embryo transfer is typically 8-12 weeks: 2-4 weeks of cycle preparation and stimulation, egg retrieval and blastocyst culture (Days 1-6), embryo vitrification, 10-14 days for genetic results, then a frozen embryo transfer (FET) cycle of approximately 3-4 weeks. For PGT-M, add 6-12 weeks of pre-cycle probe development, making the total timeline 4-6 months. HomeIVF coordinates this timeline proactively so Mumbai patients can plan work and personal commitments with clarity.
Will PGT-A guarantee a successful pregnancy?+
PGT-A significantly improves the probability of a successful pregnancy per transfer by selecting chromosomally normal embryos, but it does not guarantee success. Implantation depends on multiple factors beyond chromosomal normality — including uterine receptivity, endometrial health, thrombophilia, and immune factors. IVF success rates in India typically range from 40-55% per cycle depending on age and cause. PGT-A raises single-transfer success rates for euploid embryos into a similar range even for older patients, but a euploid embryo still carries a residual transfer failure risk that requires ongoing clinical evaluation.
Are PGT results ever wrong? What is the error rate?+
No diagnostic test is 100% accurate. NGS-based PGT-A has a reported diagnostic accuracy of 98-99% for detecting whole-chromosome aneuploidy. Rare sources of error include mosaicism — where an embryo contains a mixture of normal and abnormal cells — which can lead to either false positives (a viable embryo discarded) or false negatives (an abnormal embryo transferred). Segmental errors are also harder to classify. HomeIVF's genetic counsellors explain mosaicism categories and the clinical guidance around mosaic embryo transfer, following PGDIS consensus guidelines, so Mumbai patients make informed decisions about borderline results.
Can I do PGT if I am doing IVF at a clinic in Thane or Navi Mumbai?+
Yes. PGT requires only that your IVF clinic has an embryologist trained in blastocyst biopsy and a vitrification programme, and that biopsied samples can be transported to a NABL-accredited genetics laboratory under appropriate conditions. Many clinics in Thane and Navi Mumbai now have these capabilities, or have established transport agreements with Mumbai city labs. HomeIVF coordinates directly with partner clinics across Mumbai's suburbs to ensure that geographic location does not prevent access to genetic testing for patients who clinically need it.
